Delivery Order SPE2DB20D2104-SPE2DB25FMSDE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,713.43 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol. This firm fixed-price, non-set-aside delivery order was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a routine...
- The Defense Logistics Agency awarded a $7,508.38 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 (a combination respiratory medication), with an ultimate completion date of November 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $6,173.80 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation medication used in respiratory disease management. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. Performance is to be completed by November 14, 2025, with the product delivered to Conshohocken, Pennsylvania, the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (a combination respiratory medication) in the amount of $9,582.39 with an ultimate completion date of September 24, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $7,298.96 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol used to treat chronic obstructive pulmonary disease. The order, placed on August 18, 2025, with an ultimate completion date of August 19, 2025, was competitively awarded without set-aside designation under firm fixed-price terms. This delivery order represents a child...
- The Defense Logistics Agency awarded a $15,243.87 delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Trelegy Ellipta 100-62.5-25 (a combination respiratory medication) in a 60-dose configuration. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as...
- The Defense Logistics Agency awarded a $31,540.49 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of May 13, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $3,753.67 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation medication used in respiratory disease management. The contract is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $51,571.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination inhalation medication used in respiratory disease management. This firm fixed price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,279.40 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 19, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMSDEDelivery Order
The Defense Logistics Agency awarded a $13,755.65 delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication containing fluticasone, umeclidinium, and vilanterol. The order, with an ultimate completion date of June 2, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialty pharmaceuticals to support military healthcare programs and other federal healthcare systems worldwide. The delivery order represents a routine pharmaceutical supply transaction within the company's extensive portfolio of federal medical procurement activities supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 5/30/25 |